Anixa Biosciences Stock Today
| ANIX Stock | USD 3.31 0.01 0.30% |
Performance2 of 100
| Odds Of DistressLess than 44
|
Anixa Biosciences is trading at 3.31 as of the 29th of November 2024; that is 0.3 percent decrease since the beginning of the trading day. The stock's open price was 3.32. Anixa Biosciences has about a 44 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Anixa Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of January 1987 | Category Healthcare | Classification Health Care |
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California. Anixa Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 32.18 M outstanding shares of which 411.56 K shares are presently shorted by private and institutional investors with about 3.58 trading days to cover. More on Anixa Biosciences
Follow Valuation Profit Patterns Odds of Bankruptcy
Fiscal Year End 21st of January 2025
Anixa Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Amit Kumar | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAnixa Biosciences can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Anixa Biosciences' financial leverage. It provides some insight into what part of Anixa Biosciences' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anixa Biosciences (ANIX) is traded on NASDAQ Exchange in USA. It is located in 3150 Almaden Expressway, San Jose, CA, United States, 95118 and employs 4 people. Anixa Biosciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 106.51 M. Anixa Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 32.18 M outstanding shares of which 411.56 K shares are presently shorted by private and institutional investors with about 3.58 trading days to cover.
Anixa Biosciences currently holds about 31.66 M in cash with (6.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03.
Check Anixa Biosciences Probability Of Bankruptcy
Ownership AllocationAnixa Biosciences holds a total of 32.18 Million outstanding shares. Anixa Biosciences shows 5.05 percent of its outstanding shares held by insiders and 17.4 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Anixa Ownership Details
Anixa Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bank Of New York Mellon Corp | 73 K | ||
| Northern Trust Corp | 2024-09-30 | 71 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 69 K | |
| Corecap Advisors, Llc | 2024-06-30 | 46.9 K | |
| Tyler-stone Wealth Management | 2024-09-30 | 42 K | |
| Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 41.1 K | |
| International Assets Investment Management, Llc | 2024-09-30 | 37.8 K | |
| Ci Private Wealth Llc | 2024-06-30 | 37.4 K | |
| Gemmer Asset Management Llc | 2024-06-30 | 35 K | |
| Vanguard Group Inc | 2024-09-30 | 1.4 M | |
| Davidson D A & Co | 2024-06-30 | 736.4 K |
Anixa Biosciences Historical Income Statement
Anixa Stock Against Markets
Already Invested in Anixa Biosciences?
The danger of trading Anixa Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Anixa Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Anixa Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Anixa Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Anixa Stock Analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.